Navigation Links
Monell Center receives $100,000 Grand Challenges Explorations grant
Date:5/4/2009

The Monell Center announced today that it has received a US$100,000 Grand Challenges Explorations grant from the Bill & Melinda Gates Foundation. The grant will support an innovative global health research project conducted by Paul A. S. Breslin, PhD, titled "Taste-Guided Behavior on Mosquitoes Helps Eradicate Malaria."

Dr. Breslin's project is one of 81 grants announced by the Gates Foundation in the second funding round of Grand Challenges Explorations, an initiative to help scientists around the world explore bold and largely unproven ways to improve health in developing countries. The grants were provided to scientists in 17 countries on six continents.

To receive funding, Breslin showed in a two-page application how his idea falls outside current scientific paradigms and might lead to significant advances in global health. The initiative is highly competitive, receiving more than 3,000 proposals in this round.

Breslin's grant focuses on the sense of taste in mosquitoes, with the overall goal of identifying new strategies to reduce transmission of malaria. Taste provides information that regulates whether a substance will be ingested as food or rejected. As such, the final decision of whether or not a mosquito will initiate a meal of human blood depends on how human skin tastes to the mosquito. Currently, little is known about the taste world of mosquitoes. Dr. Breslin proposes that a deeper understanding of mosquito taste will reveal novel approaches to the design of strategies to reduce mosquito-mediated disease transmission. As a first step, the studies funded by the Grand Challenges Explorations grant will assess taste responses of mosquitoes to a range of human skin compounds.

Paul Breslin is a sensory psychobiologist and geneticist at the Monell Chemical Senses Center in Philadelphia. The Grand Challenges Explorations mosquito project is an extension of his longstanding interests in taste and feeding. Breslin's Drosophila Chemosensory Laboratory at Monell uses the fruit fly as a model to understand the relationships between genetics, chemosensation, and feeding. Parallel studies in Breslin's lab address the genetics of taste, smell, and chemical irritation in humans.

"By deterring mosquito tasting on human skin, we can help to stop the transmission of devastating diseases such as malaria," said Breslin. "The Grand Challenges Explorations grant will enable us to find out what it is about humans that mosquitoes find tasty. With that critical piece of information, we can then develop inhibitors to those substances. Once humans no longer taste good to mosquitoes, they will no longer use us as food."

"The winners of these grants are doing truly exciting and innovative work," said Dr. Tachi Yamada, president of the Gates Foundation's Global Health Program. "I'm optimistic that some of these exploratory projects will lead to life-saving breakthroughs for people in the world's poorest countries."


'/>"/>

Contact: Leslie Stein
stein@monell.org
267-519-4707
Monell Chemical Senses Center
Source:Eurekalert

Related medicine news :

1. Study Reveals How Salmonella Hijacks Cells
2. Raw Nuts Could Be Salmonella Source in Pistachios: Report
3. FDA Investigating Salmonella-Tainted Pistachios
4. Study shows how Salmonella survives in environment
5. Food Safety Expert: Americans Not Aware of Ongoing Risk & Complications of Salmonella Poisoning
6. Space Research May Help Explain Salmonella Illness
7. Study suggests surface water contaminated with salmonella more common than thought
8. Latherow Law Office Filed Suit In Salmonella Poisoning Case That Hospitalized Child
9. LegalView Informs Readers of New Criminal Probe Involving Peanut Butter Recall Salmonella Poisonings
10. Obama Orders Review of FDA in Salmonella Outbreak
11. ISU researchers develop technique for quick detection of Salmonella
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2017)... ... June 25, 2017 , ... CareSet Labs released the Root ... Orleans. This is a new, greatly improved version of the Doctor Referral teaming dataset ... by Fred Trotter and subsequently called the the “Doctor Referral Dataset” as released by ...
(Date:6/24/2017)... York (PRWEB) , ... June 24, 2017 , ... ... the Dental365 family. Located at 217 Portion Road in Lake Ronkonkoma, Dental365 offers ... evenings and weekends so that visits to the dentist fit into their patients’ ...
(Date:6/23/2017)... ... 23, 2017 , ... By scoring 100% for fiscal management and accountability, the ... online charity evaluator, Charity Navigator, validating ANRF's work as a top charity in America. ... Charity Navigator and earns ANRF a spot on their “ 10 Charities Worth Watching ...
(Date:6/23/2017)... ... 2017 , ... Military Connection friend and veteran advocate Micaela Bensko ... Atlantic lounge. , Bensko is no stranger to the plight of the disabled. ... life to supporting our wounded veterans. A world-class photographer, her riveting photos “The Wounds ...
(Date:6/23/2017)... ... 2017 , ... Georgia State University will host the First ... two-day conference is focused on advancing scientific knowledge about the aggressive triple negative ... racial breast cancer-related disparities. The conference theme is “Illuminating Actionable Biology.” , Conference ...
Breaking Medicine News(10 mins):
(Date:6/9/2017)... , June 9, 2017 AirXpanders, Inc. (ASX: ... on the design, manufacture, sale and distribution of the ... the progress of its commercial roll-out in ... in more than one hundred (100) medical institutions and ... AeroForm offers a needle-free alternative for women who choose ...
(Date:6/7/2017)... Endo International plc (NASDAQ: ENDP ) today ... R. Goodwin , U.S. District Court Judge for the ... entered a case management order in MDL 2325, American ... (the "MDL") that includes a provision requiring plaintiffs in ... specific causation within one hundred twenty (120) days of ...
(Date:6/3/2017)... , June 3, 2017  Eli Lilly and ... that results from the Phase 3 MONARCH 2 ... & 6 inhibitor, in combination with fulvestrant, significantly ... fulvestrant alone in women with hormone-receptor-positive (HR+), human ... cancer who have relapsed or progressed after endocrine ...
Breaking Medicine Technology: